Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYEW.L Regulatory News (YEW)

  • There is currently no data for YEW

Form 8.3 - YEW ID

2 Dec 2021 15:30

RNS Number : 3714U
Syquant Capital
02 December 2021
Β 

Ap19

Β 

Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Syquant Capital

Company dealt in

Yew Grove REIT plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

EUR 0.01 ordinary shares

Date of dealing

December 1st, 2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Β 

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

(2) Derivatives (other than options)

1,800,000 (1.44%)

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

1,800,000 (1.44%)

Β 

Β Β Β Β Β Β Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

Β 

(2) Derivatives (other than options)

Β 

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Β 

Increased long

1,800,000

0.995 EUR

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

Β 

Β 

Β 

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ 

votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ 

orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β YES/NO

Β 

Date of disclosure

December 2nd, 2021

Contact name

Alexandre Chevtchenko

Telephone number

+33 1 42 56 92 93

If a connected EFM, name of offeree/offeror with which connected

Β 

If a connected EFM, state nature of connection (Note 10)

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ISEFSDFSEEFSEDE
Date   Source Headline
30th Jun 20207:00 amRNSLTIP Option Awards / PDMR Notification
29th Jun 202012:24 pmRNSSecond Quarter Dividend
18th Jun 20204:49 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSRent Collection Update
29th May 20201:09 pmRNSResult of EGM
29th May 20201:02 pmRNSResult of AGM
19th May 202010:18 amRNSUpdate on upcoming General Meetings
28th Apr 202011:27 amRNSAnnual Report and Notice of AGM and EGM
24th Apr 20207:00 amRNSPublication of Annual Report
15th Apr 20207:00 amRNSTrading and Covid-19 Update & Dividend Declaration
6th Apr 20205:00 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSPreliminary Results
3rd Mar 20204:27 pmRNSFacility Increase
13th Feb 202012:06 pmRNSFourth Quarter Dividend
7th Feb 20207:00 amRNSCompletion of Acquisition
31st Jan 20207:00 amRNSFacility Increase
23rd Jan 20202:00 pmRNSChange of Adviser
23rd Jan 20208:38 amRNSDirector Declaration
16th Jan 20203:51 pmRNSHolding(s) in Company
9th Jan 20205:57 pmRNSHolding(s) in Company
20th Dec 20196:08 pmRNSCompletion of acquisition of office building
19th Dec 20192:55 pmRNSAcquisition of portfolio of six office properties
10th Dec 201910:59 amRNSDirector/PDMR Shareholding
10th Dec 201910:58 amRNSDirector/PDMR Shareholding
10th Dec 201910:57 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:56 amRNSDirector/PDMR Shareholding
10th Dec 201910:54 amRNSDirector/PDMR Shareholding
9th Dec 20192:02 pmRNSHolding(s) in Company
6th Dec 20193:20 pmRNSHolding(s) in Company
6th Dec 20198:00 amRNSEuronext Growth Dublin Notice
4th Dec 20193:42 pmRNSResult of Placing
22nd Nov 20197:00 amRNSProposed Placing
11th Nov 20197:00 amRNSSale of non-core property
1st Nov 20197:00 amRNSIDA Ireland Building Acquisition
26th Sep 20194:39 pmRNSThird Quarter Dividend
4th Sep 20191:50 pmRNSInterim Results
19th Jul 20193:30 pmRNSAcquisition of Portfolio
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:40 pmRNSDirector/PDMR Shareholding
15th Jul 20194:36 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
15th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20198:00 amRNSEuronext Growth Dublin Notice
11th Jul 20195:07 pmRNSRevolving Loan Facility Increase
11th Jul 201912:20 pmRNSResult of EGM and Total Voting Rights
26th Jun 20193:05 pmRNSSecond Quarter Interim Dividend Confirmation
18th Jun 201912:00 pmRNSResult of Placing and Notice of EGM
13th Jun 20197:00 amRNSAnnouncement of Share Issuance Programme
29th May 20193:27 pmRNSLease surrender

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.